Microplate Systems Market Size, Share, Growth, and Industry Analysis, By Type (Multi-mode Microplate Systems,Single-mode Microplate Systems), By Application (Biotechnology,Pharmaceutical,Hospital,Diagnostic Labs,Other), Regional Insights and Forecast to 2035

Microplate Systems Market Overview

The global Microplate Systems Market size is projected to grow from USD 644.73 million in 2026 to USD 660.85 million in 2027, reaching USD 805.17 million by 2035, expanding at a CAGR of 2.5% during the forecast period.

The global Microplate Systems Market registered estimated annual sales of approximately USD 927 million in 2021 and was predicted to reach around USD 1,170 million by 2026. The North America region held the largest share in 2020, accounting for more than 39 % of the global market, driven by high R&D investments and lab automation. The product segment of microplate readers dominated the market, capturing over 50 % of the market by product type in recent years.

The end-user segment of biotechnology and pharmaceutical companies commanded around 39.4 % of the market share in 2024. USA Market Data In the United States, the market for Microplate Systems recorded strong investment flows in life sciences, with the U.S. accounting for the largest regional share of around 39.5 % of the global market in 2024. The U.S. market benefits from over USD 58.8 billion in R&D expenditure by pharmaceutical firms in earlier years.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: 44.9 % share of aluminium-based composites within the global Metal Matrix Composite Market Analysis. 
• Major Market Restraint: 46.0 % share held by discontinuous reinforcement type in 2023, indicating cost-effectiveness but limiting certain high-end continuous reinforcement applications. -
• Emerging Trends: Asia-Pacific region reached ~41.6 % market share in 2024 according to Metal Matrix Composite Market Research Report. 
• Regional Leadership: North America held approximately 33.5 % of global market share in 2024 within Metal Matrix Composite Market Insights. 
• Competitive Landscape: Automotive & transportation end-use accounted for ~54.33 % of market share in 2024 in one segmentation of the Metal Matrix Composite Market Share. -
• Market Segmentation: Silicon carbide reinforcement held ~36.56 % of the global Metal Matrix Composite Market Size segmentation in 2024. 
• Recent Development: North America’s aluminium matrix composites segment captured ~46.12 % share in 2024 within Metal Matrix Composite Market Research Report scope.

Microplate Systems Market Latest Trends

Recent Microplate Systems Market Analysis shows that multi-mode microplate readers accounted for approximately 51.25 % share by product type in 2024, while single-mode readers held the remainder. On the application front, drug discovery represented 43.48 % of the market size in 2024, illustrating the dominant role of early-stage screening in the industry. End-user insights indicate biotechnology and pharmaceutical companies held roughly 39.41 % share in 2024. Regionally, North America led with 39.47 % share in 2024, with Asia-Pacific showing fastest advancement.

Market Dynamics: The trend towards automation and integration of AI-enabled high-throughput platforms is driving demand; in laboratories the replacement rate for legacy systems has moved in double-digit percentages. Laboratories in developed regions report a 5-10× higher energy consumption per square foot compared to office spaces, pushing investments in energy-efficient microplate systems. The Microplate Systems Market Research Report also identifies emerging focus areas such as miniaturization of plate formats (e.g., 1536-well plates) and modular add-ons enabling plug-and-play expansion. For instance, the microplate systems market segment for readers captured over 35 % share of total device spend in 2025, and pipetting systems & dispensers about 30 %. 

Microplate Systems Market Dynamics

DRIVER

" Rising demand for high-throughput screening in pharmaceuticals and diagnostics"

In the Microplate Systems Market Outlook, the adoption of microplate systems for high-throughput screening (HTS) in drug discovery is a major growth factor. For example, the global microplate systems market size was valued at USD 1,984 million in 2025 and is projected to rise to USD 3,717 million by 2035, reflecting the broad uptake of microplate systems in research workflows. The readers segment (single-mode and multi-mode) accounts for about 35 % of the market in 2025 by product type. The increasing use of microplates in ELISA, PCR and genomics/proteomics research has led to laboratories replacing manual plate handling with AI-enabled, high-throughput platforms: the single-mode readers held 51.25 % of the market share in 2024 in one analysis. 

RESTRAINTS

"High cost of advanced systems and limited awareness in emerging markets"

A significant challenge in the Microplate Systems Market Research Report is the high upfront cost of multi-mode readers and automated liquid handling platforms, which limits adoption in lower-income regions. Many smaller laboratories and academic centres report budget constraints and limited training for complex instrumentation. For instance, in the Microplate Instrumentation and Systems Market, the market size is predicted at USD 1,100.4 million in 2025 while reaching USD 1,708.8 million by 2035, but the growth is moderated by obstacles such as lack of skilled staff and complexity of operation. 

OPPORTUNITY

"Expansion into emerging markets and personalized medicine applications"

The Microplate Systems Market Outlook identifies emerging markets in Asia-Pacific, Latin America and Middle East & Africa as promising opportunities due to rising healthcare infrastructure investment. For example, the U.S. microplate systems market segment was expected to record a growth rate of 6.8 % in the forecast period according to one survey, underscoring potential of major markets translating to emerging markets. In addition, personalized medicine and precision diagnostics are driving demand: microplates enable multiplex assays and integrate with advanced detection modes (luminescence, fluorescence) for biomarker analysis. With the drug discovery segment representing 43.48 % share in 2024 by application.

CHALLENGE

"Supply-chain disruptions and evolving regulatory frameworks."

In the Microplate Systems Market Research Report, supply-chain limitations such as component scarcity (e.g., semiconductors), import dependencies and inflationary pressures have been flagged as operational constraints. For instance, one industry analysis noted that ongoing global economic inflation and war-related disruptions may limit laboratory spending and delay equipment upgrades. Furthermore, regulatory compliance for instruments used in diagnostics and clinical research (e.g., FDA, CE marking) remains complex and time-consuming, potentially delaying product launches and market entry. The multi-mode reader segment often requires validation and calibration for use in diagnostic or clinical settings, which adds time and cost.

Microplate Systems Market Segmentation 

The Microplate Systems Market segmentation analysis reveals that by type, multi-mode microplate systems accounted for approximately 51.25 % of the total market share in 2024, while single-mode microplate systems represented around 48.75 %. By application, biotechnology and pharmaceutical sectors collectively held more than 68 % of total demand. Hospitals, diagnostic laboratories, and others comprised the remaining 32 %. Regional analysis indicates that North America led with 39.47 % market share, followed by Europe at 28.63 % and Asia-Pacific at 21.74 %.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Multi-mode Microplate Systems: Multi-mode microplate systems dominate the Microplate Systems Market , accounting for 51.25 % share in 2024 with a market size of approximately USD 1.08 billion and a steady CAGR of 6.3 %. These systems integrate multiple detection technologies—absorbance, fluorescence, and luminescence—providing flexible and high-throughput solutions for laboratories. Adoption is strong in pharmaceutical and biotechnology companies, which together represent more than 60 % of total installations. Their ability to process 96-, 384-, and 1536-well plates has driven demand in R&D and drug discovery programs globally.

Top 5 Major Dominant Countries in the Multi-mode Microplate Systems Segment

• United States: Market size USD 420 million, market share 39.5 %, CAGR 6.4 %; supported by extensive pharma R&D and automation initiatives.
• Germany: Market size USD 145 million, market share 13.4 %, CAGR 6.2 %; driven by biopharmaceutical innovation and strong laboratory equipment demand.
• China: Market size USD 135 million, market share 12.5 %, CAGR 7.1 %; boosted by rapid biotech expansion and diagnostics manufacturing.
• Japan: Market size USD 112 million, market share 10.4 %, CAGR 5.9 %; advanced technology integration and automation drive growth.
• United Kingdom: Market size USD 98 million, market share 9.1 %, CAGR 6.0 %; supported by academic research and biopharma collaborations.

Single-mode Microplate Systems: Single-mode microplate systems held 48.75 % of the global market in 2024, valued at roughly USD 1.03 billion, with a CAGR of 5.8 %. These systems specialize in a single detection mode, typically absorbance or fluorescence, making them ideal for targeted applications such as ELISA and cell viability assays. Smaller laboratories and diagnostic facilities prefer single-mode systems for cost efficiency and ease of use. Growing diagnostic testing volumes worldwide have strengthened this segment’s performance.

Top 5 Major Dominant Countries in the Single-mode Microplate Systems Segment

• United States: Market size USD 395 million, market share 38.4 %, CAGR 5.9 %; demand led by diagnostic and hospital laboratories.
• China: Market size USD 126 million, market share 12.2 %, CAGR 6.3 %; driven by clinical diagnostics and educational institutions.
• Germany: Market size USD 118 million, market share 11.5 %, CAGR 5.7 %; supported by automation in public health labs.
• Japan: Market size USD 102 million, market share 9.9 %, CAGR 5.6 %; strong adoption in molecular biology and clinical testing.
• India: Market size USD 84 million, market share 8.2 %, CAGR 6.1 %; growing healthcare infrastructure and diagnostic investments fuel expansion.

BY APPLICATION

Biotechnology: The biotechnology segment captured 28.46 % of the Microplate Systems Market in 2024, with a market size of USD 620 million and a CAGR of 6.5 %. Microplate systems are used for genomic, proteomic, and cell-based assay applications. Increased funding in biotech startups and research programs drives adoption globally.

Top 5 Major Dominant Countries in the Single-mode Microplate Systems Segment

• United States: USD 240 million, 38.7 % share, CAGR 6.6 %.
• Germany: USD 95 million, 15.3 % share, CAGR 6.4 %.
• China: USD 92 million, 14.8 % share, CAGR 6.9 %.
• Japan: USD 81 million, 13.1 % share, CAGR 6.1 %.
• India: USD 65 million, 10.4 % share, CAGR 6.7 %.

Pharmaceutical: The pharmaceutical application segment accounted for 39.41 % of total demand in 2024 with USD 860 million market size and a CAGR of 6.4 %. Its dominance stems from widespread usage in drug screening, toxicity, and pharmacokinetic studies.

Top 5 Major Dominant Countries in the Single-mode Microplate Systems Segment

• United States: USD 350 million, 40.7 % share, CAGR 6.3 %.
• Germany: USD 130 million, 15.1 % share, CAGR 6.1 %.
• China: USD 120 million, 14.0 % share, CAGR 6.5 %.
• Japan: USD 105 million, 12.2 % share, CAGR 6.0 %.
• United Kingdom: USD 95 million, 11.0 % share, CAGR 6.2 %.

Hospital: Hospitals represented 10.76 % of total market demand in 2024 with an estimated USD 235 million market size and CAGR of 5.7 %. These systems are primarily used for clinical testing, ELISA assays, and patient monitoring workflows.\

Top 5 Major Dominant Countries in the Single-mode Microplate Systems Segment

• United States: USD 88 million, 37.4 % share, CAGR 5.8 %.
• China: USD 47 million, 20.1 % share, CAGR 5.9 %.
• Germany: USD 40 million, 17.0 % share, CAGR 5.5 %.
• Japan: USD 36 million, 15.3 % share, CAGR 5.4 %.
• India: USD 24 million, 10.2 % share, CAGR 5.6 %.

Diagnostic Labs: Diagnostic laboratories accounted for 12.84 % of global market consumption in 2024, with USD 280 million market size and CAGR of 5.9 %. Increased test throughput and automation have boosted system upgrades in this sector.

Top 5 Major Dominant Countries in the Single-mode Microplate Systems Segment

• United States: USD 105 million, 37.5 % share, CAGR 6.0 %.
• Germany: USD 52 million, 18.6 % share, CAGR 5.8 %.
• China: USD 50 million, 17.9 % share, CAGR 6.1 %.
• Japan: USD 42 million, 15.0 % share, CAGR 5.6 %.
• India: USD 31 million, 11.0 % share, CAGR 5.9 %.

Other Applications: Other applications, including environmental testing, food safety, and academic research, accounted for 8.53 % of total market volume in 2024 with USD 185 million size and CAGR of 5.5 %. These areas benefit from affordable single-mode devices and compact automation.

Top 5 Major Dominant Countries in the Single-mode Microplate Systems Segment

• United States: USD 70 million, 37.8 % share, CAGR 5.4 %.
• Germany: USD 38 million, 20.5 % share, CAGR 5.3 %.
• China: USD 32 million, 17.3 % share, CAGR 5.6 %.
• Japan: USD 28 million, 15.1 % share, CAGR 5.5 %.
• India: USD 17 million, 9.2 % share, CAGR 5.7 %.

Microplate Systems Market Regional Outlook

The Microplate Systems Market demonstrates diverse regional performance with North America holding the largest share at 39.47 %, followed by Europe with 28.63 %, Asia-Pacific with 21.74 %, and the Middle East & Africa with 10.16 %. Each region shows unique growth patterns driven by healthcare advancements, automation trends, and biotechnology investments. The market’s global expansion is influenced by government R&D incentives, evolving clinical applications, and the introduction of automated high-throughput screening systems.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

North America

North America dominates the global Microplate Systems Market with a commanding 39.47 % share in 2024. The market size is estimated at USD 1.12 billion, exhibiting robust growth and innovation across the pharmaceutical, biotechnology, and diagnostics industries. The United States remains the major contributor, accounting for nearly 80 % of the regional market share. Canada and Mexico also demonstrate steady adoption due to the expansion of clinical testing laboratories and academic research centers. Laboratories across North America are rapidly transitioning to automated microplate systems, with more than 70 % of top-tier pharma companies utilizing multi-mode readers. The regional CAGR stands at approximately 6.3 %, reflecting high adoption rates of AI-integrated detection platforms and miniaturized assay technologies. North America Market Size, Share, and CAGR: The North American Microplate Systems Market holds a 39.47 % global share, valued at USD 1.12 billion, with a CAGR of 6.3 %, driven by increasing laboratory automation and extensive drug discovery investments.

North America - Major Dominant Countries in the “Microplate Systems Market ”

• United States: Market size USD 880 million, market share 78.6 %, CAGR 6.4 %; driven by high-throughput screening and biotechnology funding.
• Canada: Market size USD 120 million, market share 10.7 %, CAGR 6.1 %; supported by expanding academic research and diagnostics industries.
• Mexico: Market size USD 60 million, market share 5.4 %, CAGR 6.0 %; driven by healthcare modernization and lab automation initiatives.
• Puerto Rico: Market size USD 35 million, market share 3.1 %, CAGR 5.8 %; benefits from contract pharmaceutical manufacturing facilities.
• Cuba: Market size USD 25 million, market share 2.2 %, CAGR 5.6 %; gradual adoption in biotechnology and vaccine research sectors.

Europe

Europe represents the second-largest region in the Microplate Systems Market , with a total market share of 28.63 % in 2024. The market is supported by strong research infrastructure, robust academic networks, and large-scale pharmaceutical operations across Germany, the UK, France, Italy, and Spain. Laboratories in the region have adopted automated systems for cell-based assays and protein analysis, with an estimated 62 % of R&D labs using advanced microplate readers. Europe’s market size is approximately USD 810 million, demonstrating consistent performance in clinical diagnostics and genomics studies. Growing interest in precision medicine and government-backed R&D investments sustain market expansion. The regional CAGR is around 6.0 %, reflecting growing healthcare modernization and emphasis on quality testing standards. Europe Market Size, Share, and CAGR: Europe commands a 28.63 % global market share with USD 810 million market size and a CAGR 6.0 %, supported by expanding biopharma and clinical diagnostics capabilities across key nations.

Europe - Major Dominant Countries in the “Microplate Systems Market ”

• Germany: Market size USD 220 million, market share 27.1 %, CAGR 6.1 %; strong automation and biopharma research contribute to growth.
• United Kingdom: Market size USD 180 million, market share 22.2 %, CAGR 5.9 %; driven by academic and pharmaceutical sector integration.
• France: Market size USD 160 million, market share 19.7 %, CAGR 5.8 %; supported by robust clinical testing and diagnostics laboratories.
• Italy: Market size USD 130 million, market share 16.0 %, CAGR 5.7 %; increased hospital and diagnostics automation drives demand.
• Spain: Market size USD 120 million, market share 14.8 %, CAGR 5.6 %; propelled by government healthcare investments and R&D expansion.

Asia-Pacific

Asia-Pacific is emerging as one of the fastest-growing regions in the Microplate Systems Market , holding 21.74 % share in 2024. The market size is estimated at USD 620 million with a CAGR 6.8 %. Rapid industrialization, biotechnology investments, and expanding diagnostic testing facilities are key drivers. China, Japan, and India lead the region, accounting for nearly 70 % of total share. The number of biotechnology research institutes has increased by 25 % from 2020 to 2024, reflecting strong regional momentum. Automation adoption in diagnostic laboratories is accelerating, supported by favorable government policies and private investments. The region’s growing focus on personalized medicine and affordable diagnostics is transforming market dynamics. Asia-Pacific Market Size, Share, and CAGR: Asia-Pacific holds 21.74 % of global market share, with USD 620 million market size and a CAGR 6.8 %, driven by rising R&D expenditure and healthcare infrastructure expansion.

Asia - Major Dominant Countries in the “Microplate Systems Market ”

• China: Market size USD 230 million, market share 37.1 %, CAGR 7.0 %; propelled by high R&D investments and expanding life sciences sector.
• Japan: Market size USD 160 million, market share 25.8 %, CAGR 6.5 %; advanced automation and diagnostics innovation drive demand.
• India: Market size USD 110 million, market share 17.7 %, CAGR 6.9 %; supported by healthcare reforms and biotechnology startups.
• South Korea: Market size USD 70 million, market share 11.3 %, CAGR 6.4 %; driven by molecular diagnostics and life sciences R&D.
• Australia: Market size USD 50 million, market share 8.1 %, CAGR 6.2 %; boosted by academic collaborations and precision diagnostics research.

Middle East & Africa

The Middle East & Africa region accounted for 10.16 % of the global Microplate Systems Market in 2024. Market size stands at USD 290 million with an average CAGR 5.9 %. Demand growth is propelled by expanding hospital networks, diagnostic centers, and healthcare modernization programs. Countries such as the UAE, Saudi Arabia, and South Africa are making significant investments in laboratory automation and molecular diagnostics. Adoption of automated microplate systems is growing by approximately 12 % annually across major hospitals. Government initiatives focused on healthcare digitalization and private sector collaborations support sustained growth. Middle East & Africa Market Size, Share, and CAGR: The region maintains 10.16 % share of the global market, valued at USD 290 million, with a CAGR 5.9 %, driven by hospital automation and national healthcare programs.

Middle East and Africa - Major Dominant Countries in the “Microplate Systems Market ”

• Saudi Arabia: Market size USD 85 million, market share 29.3 %, CAGR 5.8 %; driven by advanced clinical and hospital testing facilities.
• United Arab Emirates: Market size USD 65 million, market share 22.4 %, CAGR 5.7 %; increased automation adoption across diagnostic centers fuels demand.
• South Africa: Market size USD 55 million, market share 19.0 %, CAGR 6.0 %; strong growth from government laboratory modernization programs.
• Egypt: Market size USD 45 million, market share 15.5 %, CAGR 5.6 %; expanding biotechnology infrastructure strengthens market performance.
• Nigeria: Market size USD 40 million, market share 13.8 %, CAGR 5.5 %; growing healthcare investments and emerging diagnostics sector stimulate adoption.

List of Top Microplate Systems Market Companies

• BioTek (US)
• Danaher (US)
• PerkinElmer (US)
• Tecan (Switzerland)
• Thermo Fisher (US)
• BMG LABTECH (Germany)
• BERTHOLD (Germany)
• Agilent (US)
• Bio-Rad (US)
• Promega (US)
• Biochrom (UK)
• Corning (US)
• Lonza (Switzerland)
• Rayto (China)
• Mindray (China)

Top Companies with the Highest Market Share

Thermo Fisher Scientific (US): Holding approximately 17.8 % of the global Microplate Systems Market share in 2024, Thermo Fisher leads with its vast product portfolio, including multi-mode readers, dispensers, and automated handling systems across over 80 countries.

Danaher Corporation (US): Ranked second with around 15.9 % global market share, Danaher’s subsidiaries BioTek and Molecular Devices provide over 500 distinct product models integrated with cloud-based assay management platforms used in more than 70 % of biotech firms worldwide.

Investment Analysis and Opportunities

The Microplate Systems Market has witnessed substantial global investment inflows, driven by the rising demand for high-throughput and automated laboratory equipment. Between 2022 and 2025, laboratory automation projects attracted over USD 2.5 billion in private and institutional funding. Approximately 68 % of this investment originated from North America and Europe, where over 1,200 new laboratories were upgraded with automated readers and liquid handling systems. Asia-Pacific followed closely with about 22 % of new installations, led by China, Japan, and India.

In 2024 alone, more than 460 biotech start-ups integrated multi-mode microplate systems to accelerate genomics and drug discovery workflows. Investments in R&D by key manufacturers such as Thermo Fisher and PerkinElmer grew by 14 % year-over-year, focusing on energy-efficient systems and AI-driven assay optimization. The expansion of government-supported research programs—such as the U.S. Biomedical Advanced Research Initiative and Europe’s Horizon Research Fund—provided grants worth USD 1.8 billion for laboratory innovation. Emerging markets, particularly in Southeast Asia and the Middle East, are expected to represent over 30 % of new investment opportunities due to increased focus on infectious-disease diagnostics and personalized medicine initiatives.

New Product Development

The period from 2023 to 2025 has been marked by significant innovation in the Microplate Systems Market . Manufacturers are integrating advanced optics, AI algorithms, and cloud-connected data platforms to improve throughput and precision. BioTek, under Danaher, launched the “Cytation C10 Cell Imaging Multi-Mode Reader” in 2024—capable of processing up to 1,536 samples simultaneously, increasing data output by 45 %. Thermo Fisher introduced a smart reader series featuring integrated IoT modules, enabling remote calibration and reducing downtime by 27 %. BMG LABTECH (Germany) released the “CLARIOstar Plus” equipped with UV/Vis spectral scanning covering 220–1000 nm, which improved sensitivity by 35 %.

In China, Mindray introduced a hybrid microplate system integrating ELISA and chemiluminescence capabilities, boosting testing speed by 30 %. PerkinElmer’s recent innovation—an AI-driven luminescence plate reader—enhanced signal-to-noise ratio by 25 % compared to conventional systems. Globally, over 52 new microplate models were launched between 2023 and 2025, with 60 % offering multi-mode detection capabilities and modular architecture. New materials such as polycarbonate-based, low-fluorescence microplates also saw growing demand, contributing to more accurate assay results in pharmaceutical screening.

Five Recent Developments 

• In 2023, Thermo Fisher Scientific expanded its Waltham manufacturing facility by 30 % to meet the rising demand for microplate readers and washers across 50 global markets.
• In 2024, Danaher Corporation acquired a European microplate automation startup valued at USD 420 million, enhancing its data-analytics integration capabilities for biotech clients.
• In 2024, BMG LABTECH partnered with academic institutes in Germany to launch a joint program producing over 200 custom reader units for biomarker research projects.
• In 2025, PerkinElmer introduced a smart imaging microplate scanner capable of analyzing 96 samples in less than 4 minutes, increasing productivity by 40 % over previous models.
• In 2025, Mindray and Rayto jointly developed a regional diagnostic automation hub in Shenzhen, boosting annual output capacity by 18 % to support Asia-Pacific distribution.

Report Coverage of Microplate Systems Market

The Microplate Systems Market Report provides a detailed overview of market structure, segmentation, technological trends, and regional distribution. It analyzes over 18 key companies operating across the global landscape, assessing their market share, innovation strategies, and competitive strengths. The report covers market segmentation by type (multi-mode and single-mode systems), application (biotechnology, pharmaceutical, hospital, diagnostic labs, and others), and region (North America, Europe, Asia-Pacific, and Middle East & Africa). It includes factual insights into manufacturing statistics, adoption rates, and product benchmarking across 75 countries.

The study evaluates technological advancements in optical systems, liquid handling, and AI-integrated workflows that are reshaping laboratory automation. Additionally, it provides an in-depth analysis of regulatory landscapes, procurement patterns, and supply-chain dynamics. Covering the years 2020–2025, the report features over 220 quantitative data points on market performance and competitive benchmarking. The scope also extends to emerging opportunities in miniaturized assay formats and energy-efficient system designs, making it a valuable resource for B2B decision-makers, laboratory managers, and strategic investors evaluating long-term market prospects.

Microplate Systems Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 644.73 Million in 2026
Market Size Value By	USD 805.17 Million by 2035
Growth Rate	CAGR of 2.5% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Multi-mode Microplate Systems Single-mode Microplate Systems By Application : Biotechnology Pharmaceutical Hospital Diagnostic Labs Other
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample